Adgero Biopharmaceuticals to Present at Biotech Showcase 2017
PRINCETON, NJ--(Marketwired - January 05, 2017) - Adgero Biopharmaceuticals Holdings, Inc. ("Adgero" or the "Company"), a privately-held biopharmaceutical company leveraging its late stage photodynamic therapy ("PDT") platform …